Recent advances in nanotechnology have seen the development of a number of microbiocidal and/or anti-adhesive nanoparticles displaying activity against biofilms. In this work, trimeric thiomannoside clusters conjugated to nanodiamond particles (ND) were targeted for investigation. NDs have attracted attention as a biocompatible nanomaterial and we were curious to see whether the high mannose glycotope density obtained upon grouping monosaccharide units in triads might lead to the corresponding ND-conjugates behaving as effective inhibitors of E. coli type 1 fimbriae-mediated adhesion as well as of biofilm formation. The required trimeric thiosugar clusters were obtained through a convenient thiolene "click" strategy and were subsequently conjugated to alkynyl-functionalized NDs using a Cu(I)-catalysed "click" reaction. We demonstrated that the tri-thiomannoside clusterconjugated NDs (ND-Man 3 ) show potent inhibition of type 1 fimbriae-mediated E. coli adhesion to yeast and T24 bladder cells as well as of biofilm formation. The biofilm disrupting effects demonstrated here have only rarely been reported in the past for analogues featuring such simple glycosidic motifs. Moreover, the finding that the tri-thiomannoside cluster (Man 3 N 3 ) is itself a relatively efficient inhibitor, even when not conjugated to any ND edifice, suggests that alternative mono-or multivalent sugar-derived analogues might also be usefully explored for E. coli-mediated biofilm disrupting properties.
INTRODUCTION
Bacterial infectious diseases pose a major threat to human health. Several share clinical characteristics such as chronic inflammation and tissue damage, and are greatly exacerbated when microorganisms grow as biofilms on mucosal surfaces or medical devices. 1, 2 Biofilms enable the bacteria residing within them to counter and resist the action of the human immune system and to enhance their tolerance towards antibiotics, leading to infections that are very difficult to eradicate. [3] [4] [5] The threat of biofilm-related infections has been greatly aggravated with the emergence of multidrug resistant bacteria, a phenomenon that has been compounded in the past decades with the overuse and misuse of antibiotics. These and other considerations have generated an increased interest in the development of non-biocidal anti-infective strategies as alternatives to antibiotics, as these would be expected to show reduced tendency to provoke the appearance of resistant strains. [6] [7] [8] [9] [10] [11] [12] [13] One such approach is the development of a number of microbiocidal and/or anti-adhesive nanoparticles displaying activity against biofilms. [14] [15] [16] [17] [18] [19] Among the targets that have been identified for anti-adhesive nanoparticles are type 1 fimbriae, which constitute major virulence factors produced by Escherichia coli (E. coli). 20 Type 1 fimbriae are filamentous tubular structures each of 0.2-2.0 µm in length and 5-7 nm in diameter that are distributed over the entire surface of the bacterium. 21 In various E. coli strains the lectin located at the extremity of type 1 fimbriae, FimH, contributes to tissue colonization through its specific recognition of the terminal α-D-mannopyranosyl units present on cell-surface glycoproteins. FimH-mediated adhesion to such mannosyl moieties has been demonstrated to be crucial for the interaction of E. coli with uroplakins and consequently for bladder colonization. 22 Disruption of this interaction has been proposed as a promising strategy for the development of an anti-adhesive therapy. 23, 24 While a number of multivalent as well as monovalent sugar-based ligands have been reported to show promise as effective inhibitors of E. coli adhesion to eukaryotic cells, 9, 20, [25] [26] [27] [28] [29] [30] [31] multivalent presentation of carbohydrate ligands on appropriate scaffolds has been demonstrated, in several instances, to lead to significantly increased affinities for their appropriate lectin target compared to a monovalent references. [32] [33] [34] [35] [36] [37] These avidities can be dramatically superior to those arising from a simple additive effect. The types of multivalent structures targeting FimH thus far reported are very varied and range from small-to mediumsized scaffolds presenting carbohydrate-derived ligands, to larger entities such as sugardecorated polymers and nanoparticles, and a multitude of creatively designed compounds in between. 20, 38, 39 We and others have been interested in exploring whether the reported characteristic properties of nanodiamonds (NDs) might be taken advantage of in the development of useful inhibitors of type 1 fimbriae-mediated E. coli adhesion. [40] [41] [42] ND particles are completely inert, optically transparent, biocompatible and moreover, easily functionalizable via a variety of strategies depending on their intended application. [43] [44] [45] [46] [47] [48] [49] [50] Although their in vivo toxicity depends in particular on their surface characteristics (as well as the nature of the ligands they carry on their surface), 51 ND particles have thus far been reported not to induce significant cytotoxicity in a variety of cell types. [51] [52] [53] [54] The demonstration that our 1 st -generation sugarconjugated NDs do show marked anti-adhesive activity in cell-based assays without displaying toxicity against eukaryotic cells conforted us in our choice of particle and convinced us that sugar-NDs should indeed be further pursued as biomaterials. Particularly striking was the unexpected observation that these ND-mannose conjugates are able to inhibit E. coli-induced biofilm formation. Such a feature has indeed only been observed rarely for ligands of FimH but would be expected to constitute a very desirable additional attribute in any potential anti-adhesive molecule. 9, 40, 55 Moreover, anti-biofilm disrupting activity had not apparently been described previously for alternative glyco-nanoparticles (glyco-NPs) such as glycofullerenes, gold-based glyco-NPs or for other multivalent mannose-derived molecules. 33, 36, 41 The coupling strategy used for the fabrication of our 1 st -generation glyco-NDs was selected with the expectation that it would ensure not only a convenient means of conjugating carbohydrate moieties to the ND core, but also provide a linker that would itself constitute an extended ligand for FimH. In that approach propargyl sugar derivatives were ligated using a Cu(I)-catalysed Huisgen cycloaddition reaction ("click" reaction) to NDs decorated with surface azidophenyl functions. To further scrutinize the origin of the bacterial adhesion and biofilm growth inhibition activities observed for our 1 st -generation glyco-NDs, we embarked on the investigation of a second, structurally complimentary, family of sugar-conjugated NDs. It was decided that the 2 nd -generation ND-sugar conjugates were to be obtained through an alternative sugar-conjugation strategy and, in addition, would feature a trimeric thiomannoside cluster motif as a contrasting mode of surface-sugar presentation. Indeed various O-glycoside-derived trimeric clusters have been shown to be strong ligands for FimH compared with their corresponding monovalent analogues. 20, 28 Moreover, it has been demonstrated that trimeric mannoside and thiomannoside clusters, related to those proposed, often give relatively large multivalent effects towards mannose-specific lectins. [56] [57] [58] [59] [60] The sugar-linker of our 2 nd -generation ND-sugar conjugates is quite different from the one 6 featured in the 1 st -generation NDs, (synthesized through the "clicking" of propargyl glycosides to ND-grafted azido functions) and would thus very probably make different secondary interactions with the sugar-binding pocket in FimH. Furthermore, the trimeric thiosugar cluster backbone would be expected to be relatively flexible and, in addition, its peripheral thiomannosyl moieties held much further away from the ND surface than the mannosyl units featured in the 1 st -generation NDs. Taken together, we suspected that all these factors would serve to render the sugar moieties present in the targeted 2 nd -generation NDconjugates more accessible to FimH receptors on the bacterial surface than those featured in our 1 st -generation conjugates and thus give contrasting behavior in the projected biological assays.
An additional feature of the second family of glyco-NDs proposed in this work is the installation of thioglycoside linkages which would render the anomeric tethering function much more robust to acidic or enzymatic hydrolysis than the O-glycosidic functions featured in our initial ND-sugar conjugates. This strategy has been a design feature of a multitude of thioglycoside-based ligands 61 and we were surprised to discover that such a functional group motif had rarely been integrated into potential inhibitors of FimH and FimH-mediated E. coli adhesion events. Yet another difference between the 1 st -and targeted 2 nd -generation sugar-NDs is that the concentration of surface triazole functions relative to that of conjugated mannosyl moieties in the later family would be much lower than in the original ND sugarconjugates. We were curious to ascertain if inhibition of type 1 fimbriae-mediated adhesion might in some way be connected to: (i) the presence and accessibility of surface triazole functions; (ii) to the presence of multiple surface-conjugated mannosyl units; (iii) to the inherent physico-chemical characteristics of the ND core itself, or even to some combination of the three.
We show in this paper the successful integration of trimeric thiomannosyl clusters onto alkynyl-terminated NDs, to give the targeted 2 nd -generation sugar-conjugated NDs (ND-Man 3 ) ( Figure 1 ). Thiolactoside trimer-ND conjugates (ND-Lac 3 ) and ND-OH particles have also been prepared as negative controls. These compounds have all been tested as inhibitors of E. coli adhesion to yeast and also to T24 bladder cells. The thiomannosyl trimer-NDs (ND-Man 3 ), but not the negative controls, have been found to be strong inhibitors of both E. coli adhesions in both assays. In addition, these ND-Man 3 particles are shown also to inhibit E. coli-driven biofilm growth significantly.
EXPERIMENTAL

Materials
Reagents and solvents were purchased from commercial sources and used without further purification. Azo-bis(isobutyronitrile), dichloromethane, trifluoromethanesulfonic anhydride, pyridine, and N,N-dimethylformamide are indicated by the acronyms AIBN, DCM, Tf 2 O, Py, and DMF, respectively. Thin-layer chromatography (TLC) was carried out on aluminum sheets coated with Kieselgel 60 F254, with visualization by UV light and by charring with 10% H 2 SO 4 or 0.2% ninhydrin. Column chromatography was carried out on silica gel 60 (230−400 mesh). (Figure 2 ) required for the synthesis of Man 3 N 3 and Lac 3 N 3 was prepared following the reported procedure. 64 (Figure 2) . 65, 66 Full spectral data are reported in supporting material (Figures S2-S5 ). 
Synthesis of tri-thiomannoside (Man 3 N 3 ) and tri-thiolactoside (Lac 3 N 3 ) cluster ligands for ND conjugation
2,2,2-Tris[5-(α-D-mannopyranosylthio)-2-oxapentyl]ethyl azide (Man 3 N 3 ). To a solution
Determination of the carbohydrate loading on particles:
A calibration curve was established as described previously. 40 An aqueous phenol solution (5 wt%, 60 µL) and concentrated H 2 SO 4 (900 µL) was added to an aqueous carbohydrate solution (60 µL), the mixture was stirred for 10 min and then an absorption spectrum of the mixture was recorded (Perkin Elmer Lambda 950 dual beam) against a blank sample (reagent solutions without carbohydrate). The absorbance of the solution was measured at two wavelengths: λ 1 =495 and λ 2 =570 nm and the absorbance difference (A 495 -A 570 ) plotted against the concentration of the corresponding monosaccharide or disaccharide, respectively.
Then, 60 µL of a selected sugar-conjugated ND particle was suspended in water (0.8 mg mL -1 ), and treated with phenol/H 2 SO 4 and the protocol described above was applied. The concentration of conjugated sugar liberated was calculated with reference to the appropriate calibration curve. Propargyl alcohol-terminated ND particles were subjected to identical treatment and used as a blank sample.
Instrumentation
X-ray photoelectron spectroscopy: X-ray photoelectron spectroscopy (XPS) measurements
were performed with an ESCALAB 220 XL spectrometer from Vacuum Generators featuring a monochromatic Al Kα X-ray source (1486.6 eV) and a spherical energy analyzer operated in the CAE (constant analyzer energy) mode (CAE=100 eV for survey spectra and CAE = 40 eV for high-resolution spectra), using the electromagnetic lens mode. The angle between the incident X-rays and the analyzer is 58°. The detection angle of the photoelectrons is 30°.
Particle size measurements: ND suspensions (20 µg mL -1 ) in water were sonicated. The particle size of the ND suspensions was measured at 25°C using a Zetasizer Nano ZS (Malvern Instruments S.A., Worcestershire, U.K.) in 173° scattering geometry and the zeta potential was measured using the electrophoretic mode.
. 1 Bacteria were then mixed with yeast (OD 600nm 1:1) and placed in a 96-well microtiter plate and agglutination was then assessed after 10 min settling. The titer was considered as the lowest compound concentration that inhibits agglutination
NMR measurements:
Inhibition of bacterial binding to T24 bladder cells
T24 bladder cells were seeded per well into a 96-well culture plates and incubated for 24 h in the same conditions. Cell monolayer was washed three times with PBS before adding bacteria. Static bacterial cultures grown in M63B1-Gluc of the E. coli The bacterial OD 600 used in the inhibition experiment corresponds to the amount of bacteria that allows 50% of total binding to T24 cells. Each anti-adhesive compound was added at the desired final concentration to a bacterial sample of predetermined OD 600 and the mixture incubated for 15 minutes at room temperature before the binding assay. In all cases the non fimbriated isogenic strain MG1655_ λATT::amp_GFP_∆fim::cat was used as control.
Experiments were performed in triplicate, at least four times, from which the corresponding IC 50 values were computed. The levels of fluorescence thus obtained were normalized to between 100% (MG1655_ λATT::amp_GFP_kmPcL_fimAICDFGH with no compound) and 0% (MG1655_ λATT::amp_GFP_∆fim::cat with no compound). Statistical analysis was performed using GraphPad Prism software.
Eukaryotic cell toxicity assay
T24 bladder cells were incubated for 24 h with each of the ND particles, serially diluted as indicated. Cell growth was determined by the MTT reduction assay (Tox-1, Sigma Inc.).
Experiments were performed in triplicate at least three times. The activity in the absence of NDs was taken as 100%.
Inhibition of biofilm formation in microtiter plates
The inhibition of biofilm formation was assayed by determining the ability of the cells to adhere to the wells of 96-well non-tissue culture-treated polyvinyl chloride (PVC) microtiter dishes. 68 Overnight cultures were adjusted to OD 600 0.05 in M63B1-Gluc medium.
Compounds were serially diluted in M63B1-Gluc medium. Equal volumes of bacteria and each compound dilution were mixed, and 100 µL aliquots of each mixture were added to a 96-well PVC plate. The plate was then incubated at 37°C for 24 h in a humid chamber. To detect biofilm formation, wells were rinsed, and 125 µL of a 1% solution of crystal violet was added. The plates were then incubated at room temperature for 15 min and again rinsed. The (Figure 2) . The homogeneity and purity of all new structures were confirmed by mass spectrometry, NMR spectroscopy and combustion analysis. (See supporting material for NMR and HRMS spectra).
RESULTS AND DISCUSSION
Synthesis of trivalent sugar clusters for conjugation
Fabrication of sugar cluster-conjugated nanodiamonds
The precursor tri-thiomannoside (Man 3 N 3 ) and tri-thiolactoside (Lac 3 N 3 ) clusters were conjugated to the ND nanoparticles via a "click" strategy that differed from the one described for fabrication of our 1 st -generation mannose-conjugated NDs (Figure 1) . 40 In the present work, hydroxyl-terminated ND (ND-OH) was reacted with 4-pentynoic acid using N,N'dicyclohexylcarbodiimide and a catalytic amount of 4-dimethylaminopyridine (DMAP) to
give the corresponding ND-propargyl (Figure 1) . The propargyl groups thus installed on the surface of the NDs were then reacted with the appropriate azido-derivatized tri-thioglycan partner (Man 3 N 3 or Lac 3 N 3 ), respectively, in the presence of CuI(PPh 3 ) as catalyst to give the corresponding sugar cluster-clicked NDs. The successful coupling is in addition confirmed by the presence of N1s and S 2p next to C 1s and O1s in the XPS survey spectrum ( Table 1) .
The initial ND-OH particles show 1.5 at % nitrogen presence most likely generated during the detonation process where trinitrotoluene is used. The level of N1s is increased in ND-Man 3 and ND-Lac 3 particles to 5.3 and 5.2 at % respectively. The S/(N-1.5) ratio is determined as 1.03 (ND-Man 3 ) and 0.97 (ND-Lac 3 ) , close to the theoretical value of 1. The amount of sugar clicked to a given glyco-ND surface was quantified using a classical phenolsulfuric acid-based colorimetric method as has been reported previously. 40 As expected (Table 1) , the sugar loading is seen to be almost three times higher for each of the ND-trithioglycan clusters fabricated in this work than observed for the 1 st -generation ND-sugar conjugates. 40
Inhibition of type 1 fimbriae-mediated adhesion to eukaryotic cells by mannose derivatives
Two independent assays were applied to evaluate the efficiency of the tri-thiomannoside cluster-NDs to inhibit type 1 fimbriae-mediated bacterial adhesion to eukaryotic surfaces: (i) inhibition of yeast agglutination and (ii) inhibition of bacterial adhesion on the T24 bladder cell line.
Yeast agglutination assay
14
The assay is based on measuring the capacity of E. coli expressing type 1 fimbriae to aggregate yeasts through bacterial recognition of mannosylated residues present on their cell surface glycans and was performed as previously described. 40 The inhibition titer was calculated as the minimum concentration of each sugar analogue or ND derivative at which agglutination was blocked. The data are summarized in Table 2 . No inhibition of yeast aggregation was detected with either the ND-OH or tri-thiolactoside cluster-modified ND ND-Lac 3 controls. In contrast, all compounds featuring mannosyl moieties were able to inhibit the adhesion of bacteria to yeast cells to varying degrees. The ND-Man 3 particles give an inhibition titer of 3.14 µg mL -1 corresponding to a potency of 2970 relative to that of methyl α-D-mannopyranoside (α-mmp), used as a monovalent reference. In comparison, a relative potency value of 1003 was obtained with our 1 st -generation mannose-functionalized NDs in the same assay format. 40 The unconjugated tri-thiomannoside cluster Man 3 N 3 shows a potency of 32 relative to that of α-mmp. Thus, the inhibitory potential of cluster Man 3 N 3 , when conjugated to the ND particles, increased 91 times more than when unconjugated.
Bacterial binding to T24 bladder cell inhibition assay
The new glyco-NDs were evaluated for their abilty to interfere with FimH-mediated recognition by bacteria of T24 cells, a human bladder carcinoma cell line, following a previously described protocol 40 (see Figure 3) . None of the new compounds synthesized in this work exhibited any measurable cytotoxicity towards T24 cells after 24 h of incubation at the maximum concentrations to be employed in the assay (see supplementary information Figure S1 ). As expected, neither the ND-OH, nor ND-Lac 3 controls show any tendency to inhibit adherence to T24 cells in this assay ( Table 3 ). In contrast, the tri-thiomannoside cluster Man 3 N 3 was found to significantly affect the adhesion, exhibiting an inhibitory potency 229-fold higher than α-mmp in this assay. The ND-Man 3 displayed an inhibition potency of 30502 relative to that of α-mmp (a value of 9259 is obtained for our 1 st -generation mannose-functionalized NDs in this assay 40 ). The activity of the tri-thiomannoside cluster Man 3 N 3 is thus seen in this assay to be amplified some 133 times when conjugated to the ND particles.
Inhibition of biofilm formation in microtiter plates
Type 1 fimbriae are well known to promote adhesion to abiotic surfaces and to enhance biofilm formation. The initial attachment and establishment of E. coli K-12 biofilms to abiotic surfaces can be inhibited by α-mannopyranosyl containing O-glycosides and Oglycans, implicating the integral role of the FimH lectin in this process. 69 The biofilm disrupting ability of the various sugar ligands and conjugated-nanostructures fabricated in this work was evaluated, as previously described, using an assay that measures their ability to inhibit E. coli MG1655_ λATT::amp_GFP_kmPcL_fimAICDFGH biofilm formation on polyvinyl chloride (PVC) surfaces (Figure 4) . 40 Whereas neither the ND-OH nor ND-Lac 3 controls proved active (data not shown), both the unconjugated tri-thiomannoside cluster Man 3 N 3 and ND-Man 3 displayed a strong disrupting effect on biofilm formation as compared to α-mmp.
The biofilm inhibitory potency of the ND-Man 3 described herein is significantly greater than that observed for our 1 st generation sugar-NDs (ca. 10 fold). 40 NDs conjugates relative to that of smaller entities.
CONCLUSIONS
In this work we demonstrate that sugar-conjugated nanodiamonds have marked detrimental effects on E. coli-mediated biofilm formation and that this phenomenon is related to their ability to interfere with FimH-mediated bacterial adhesion. The conjugation strategy developed for these 2 nd -generation sugar conjugated NDs, using alkynyl-functionalized NDs, proves as efficient as the one described previously which was based on azido-functionalized NDs. 40 Having in hand this pair of complementary strategies for surface modification of ND particles, makes possible the application of the Huisgen Cu(I) "click" methodology to a wide range of propargyl-or azido-armed ligand counterparts thus greatly broadening its scope. The demonstration that the tri-thiomannoside cluster-NDs (ND-Man 3 ) fabricated here are able to effectively impede type 1 fimbriae-mediated bacterial adhesion in two independent assay formats is consistent with our earlier findings that mannose-conjugated NDs have a marked E.coli anti-adhesive activity.
The ability of the new glycocluster-NDs to significantly inhibit E. coli-mediated biofilm formation is remarkable. The fact that both the 1 st -(glycoside) and 2 nd -(thioglycoside) generations of glyco-NDs both manifest this property is also notable. 40 Moreover, the finding that the unconjugated trimeric thiomannoside cluster Man 3 N 3 shows a non-negligible activity as a biofilm inhibitor, despite its low relative molecular weight was unexpected. Indeed, rarely have sugar-based inhibitors of E. coli-generated biofilms been reported although a number have for biofilms mediated by Pseudomonas aeruginosa. 70, 71 The fact that Man 3 N 3
does not feature any triazole segment in the vicinity of the sugar moiety strongly suggests that the presence of the heterocycle as an integral feature of the 1 st -generation NDs is not critical for their ability to inhibit biofilm formation. In addition, neither the ND-OH nor ND-Lac 3 controls are seen to show any anti-adhesive activity, underlining that the activities observed for the thiomannosyl conjugates are sugar-specific. Taken together, the data supports that it is the presence of mannosyl residues in the thiosugar clusters that constitute the primary ingredient driving the biofilm-inhibitory activity observed for the NDconjugates: neither the presence of triazole functions or the interplay of some intrinsic physico-chemical property of the nanodiamond core itself have an obvious influence on this process.
Although it would be premature to advance a detailed explanation for this observation at this point, such biofilm inhibition effects would constitute a useful additional feature of any antiadhesive lead and has rarely been reported in the past for the alternative mono-or multivalent-mannose derivatives. We suspect that the activities brought to light in this work might not be exclusive to nanodiamond-based sugar conjugates. Moreover, the finding that the tri-thiomannosyl cluster Man 3 N 3 itself is a relatively efficient inhibitor, even when not conjugated to any ND scaffold, suggests that alternative mono-and medium-to low-valency mannosyl conjugates might also demonstrate significant E. coli-mediated biofilm disrupting properties, a hypothesis that deserves to be further investigated 
